<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Spinosad: Drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Spinosad: Drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Spinosad: Drug information</div><div class="clear"></div><div id="topicText">(For additional information <a class="drug drug_patient" data-topicid="16463" href="/d/html/16463.html" rel="external">see "Spinosad: Patient drug information"</a> and <a class="drug drug_pediatric" data-topicid="16780" href="/d/html/16780.html" rel="external">see "Spinosad: Pediatric drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
<div class="list ubnlist drugH1Div drugBrandNames" id="F11404426"><span class="drugH1">Brand Names: US</span>
<ul>
<li>Natroba</li></ul></div>
<div class="ex_sect_xr thclist drugH1Div drugBrandNames" id="F11404428"><span class="drugH1">Pharmacologic Category</span>
<ul>
<li>
                        Antiparasitic Agent, Topical;</li>
<li>
                        Pediculocide</li></ul></div>
<div class="block doa drugH1Div" id="F11506344"><span class="drugH1">Dosing: Adult</span>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="25064afa-9a59-45fb-8b65-21ea8519d52d">Head lice</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Head lice:</b>
<b>Topical:</b> Apply sufficient amount to cover dry scalp and completely cover dry hair; 120 mL may be necessary depending on the length of hair. If live lice are seen 7 days after first treatment, repeat with second application.</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="438f4c22-af5c-4e23-b93b-facec7c92d18">Scabies</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Scabies:</b>
<b>Topical:</b> Apply sufficient amount to completely cover body from the neck to the toes (including soles of the feet); apply to forehead, hairline, scalp, and temples in patients who are balding. Leave on skin for ≥6 hours prior to bathing or showering.</p></div>
</div>
</div>
<div class="block dora drugH1Div" id="F50990735"><span class="drugH1">Dosing: Kidney Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling. However, dosage adjustment unlikely due to low systemic absorption.</p></div>
<div class="block doha drugH1Div" id="F50988102"><span class="drugH1">Dosing: Hepatic Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling. However, dosage adjustment unlikely due to low systemic absorption.</p></div>
<div class="block doe drugH1Div" id="F11506345"><span class="drugH1">Dosing: Older Adult</span>
<p style="text-indent:0em;display:inline">Refer to adult dosing.</p></div>
<div class="block dop drugH1Div" id="F11506343"><span class="drugH1">Dosing: Pediatric</span><p>(For additional information <a class="drug drug_pediatric" data-topicid="16780" href="/d/html/16780.html" rel="external">see "Spinosad: Pediatric drug information"</a>)</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="25064afa-9a59-45fb-8b65-21ea8519d52d">Head lice</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Head lice:</b> Infants ≥6 months, Children, and Adolescents: Topical: Suspension: Apply sufficient amount to cover dry scalp and completely cover dry hair (maximum single application dose: 120 mL); leave on for 10 minutes and then rinse out with warm water. If live lice are seen 7 days after first treatment, repeat with second application.</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="438f4c22-af5c-4e23-b93b-facec7c92d18">Scabies</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Scabies: </b>Children ≥4 years and Adolescents: Topical: Suspension: Apply sufficient amount to cover body from neck to toes (including soles of feet). If patient is bald, apply to forehead, hairline, scalp, and temples. Allow to absorb into the skin for 10 minutes before putting on clothes. Leave on skin for ≥6 hours prior to bathing or showering.</p></div>
</div>
</div>
<div class="block dorp drugH1Div" id="F51160243"><span class="drugH1">Dosing: Kidney Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling. However, dosage adjustment unlikely due to low systemic absorption.</p></div>
<div class="block dohp drugH1Div" id="F51160244"><span class="drugH1">Dosing: Hepatic Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling. However, dosage adjustment unlikely due to low systemic absorption.</p></div>
<div class="block adr drugH1Div" id="F11502563"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified.</p>
<p style="text-indent:-2em;margin-left:2em;">1% to 10%:</p>
<p style="text-indent:-2em;margin-left:4em;">Dermatologic: Erythema of eyelid (2%), xeroderma (2%)</p>
<p style="text-indent:-2em;margin-left:4em;">Local: Application site burning (≤3%), application site erythema (3%), application site irritation (≤3%), application site pain (≤3%)</p>
<p style="text-indent:-2em;margin-left:2em;">&lt;1%:</p>
<p style="text-indent:-2em;margin-left:4em;">Dermatologic: Alopecia</p>
<p style="text-indent:-2em;margin-left:4em;">Local: Application site reactions (dryness, exfoliation)</p></div>
<div class="block coi drugH1Div" id="F11502560"><span class="drugH1">Contraindications</span>
<p style="text-indent:0em;display:inline">There are no contraindications listed in the manufacturer's labeling</p></div>
<div class="block war drugH1Div" id="F11502561"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Dosage form specific issues:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Benzyl alcohol and derivatives: Some dosage forms may contain benzyl alcohol; large amounts of benzyl alcohol (≥99 mg/kg/day) have been associated with a potentially fatal toxicity (“gasping syndrome”) in neonates; the “gasping syndrome” consists of metabolic acidosis, respiratory distress, gasping respirations, CNS dysfunction (including convulsions, intracranial hemorrhage), hypotension, and cardiovascular collapse (AAP ["Inactive" 1997]; CDC, 1982); some data suggests that benzoate displaces bilirubin from protein binding sites (Ahlfors, 2001); avoid or use dosage forms containing benzyl alcohol with caution in neonates. See manufacturer's labeling.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Other warnings/precautions:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Appropriate use: For topical use only; not for oral, ophthalmic, or intravaginal use. Avoid contact with eyes. Wash hands after application. Should be used as a part of an overall lice or scabies management program.</p></div>
<div class="block add-pediatric-warn-info drugH1Div" id="F52878775"><span class="drugH1">Warnings: Additional Pediatric Considerations</span>
<p style="text-indent:0em;display:inline">Some dosage forms may contain propylene glycol; in neonates, large amounts of propylene glycol delivered orally, intravenously (eg, &gt;3,000 mg/day), or topically have been associated with potentially fatal toxicities which can include metabolic acidosis, seizures, renal failure, and CNS depression; toxicities have also been reported in children and adults including hyperosmolality, lactic acidosis, seizures, and respiratory depression; use caution (AAP 1997; Shehab 2009).</p></div>
<div class="block foc drugH1Div" id="F13156819"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Suspension, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Natroba: 0.9% (120 mL) [contains benzyl alcohol, cetearyl alcohol, fd&amp;c yellow #6 (sunset yellow), isopropyl alcohol, propylene glycol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 0.9% (120 mL)</p></div>
<div class="block geq drugH1Div" id="F20452803"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">Yes</p></div>
<div class="block fee drugH1Div" id="F16322883"><span class="drugH1">Pricing: US</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Suspension</b> (Natroba External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.9% (per mL): $2.76</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Suspension</b> (Spinosad External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.9% (per mL): $2.64</p>
<p style="text-indent:0em;">
<b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>
<div class="block adm drugH1Div" id="F11506585"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>Topical:</b> For external use only; not for intravaginal, ophthalmic, or oral use. Avoid contact with eyes; rinse thoroughly with water if contact occurs. Shake bottle well. Wash hands after application.</p>
<p style="text-indent:-2em;margin-left:4em;">Head lice: Apply to dry scalp and rub gently until the scalp is thoroughly moistened, then apply to dry hair; completely covering scalp and hair. Leave on for 10 minutes (start timing treatment after the scalp and hair have been completely covered). The hair should then be rinsed thoroughly with warm water. Shampoo may be used immediately after the product is completely rinsed off. If live lice are seen 7 days after the first treatment, repeat with second application. Nit combing is not required, although a fine-tooth comb may be used to remove treated lice and nits.</p>
<p style="text-indent:-2em;margin-left:4em;">Scabies: Apply to dry skin covering body from the neck to the toes (including soles of the feet); apply to forehead, hairline, scalp, and temples in patients who are balding. Allow to absorb into skin and dry for 10 minutes prior to getting dressed. Do not bath or shower for at least 6 hours after applying.</p>
<p style="text-indent:-2em;margin-left:2em;margin-top:2em;">Spinosad should be a portion of a whole lice removal program, which should include washing in hot water or dry cleaning all clothing, hats, bedding and towels recently worn or used by the patient and washing combs, brushes, and hair accessories in hot water. For scabies, wash in hot water or dry clean any bedding, clothing, and towels used by anyone infected with scabies.</p></div>
<div class="block admp drugH1Div" id="F52614474"><span class="drugH1">Administration: Pediatric</span>
<p style="text-indent:0em;display:inline">Topical: Suspension: For external use only. Not for intravaginal, ophthalmic, or oral use. Avoid contact with eyes; rinse thoroughly with water if contact occurs. Apply to pediatric patients with direct adult supervision.</p>
<p style="text-indent:-2em;margin-left:2em;">Head lice: Infants ≥6 months, Children, and Adolescents: Shake bottle well before use. Apply to dry scalp and rub gently until the scalp is thoroughly moistened, then apply to dry hair, completely covering scalp and hair. Leave on for 10 minutes (start timing treatment after the scalp and hair have been completely covered). The hair should then be rinsed thoroughly with warm water. Shampoo may be used immediately after the product is completely rinsed off. Wash hands after application. If live lice are seen 7 days after the first treatment, repeat with second application. Avoid contact with the eyes; wash hands after use. Nit combing is not required, although a fine-tooth comb may be used to remove treated lice and nits from hair and scalp.</p>
<p style="text-indent:-2em;margin-left:4em;">Spinosad should be a portion of a whole lice removal program, which should include washing or dry cleaning all clothing, hats, bedding, and towels recently worn or used by the patient and washing combs, brushes, and hair accessories in hot water.</p>
<p style="text-indent:-2em;margin-left:2em;">Scabies: Children ≥4 years and Adolescents: Shake bottle well before use. Apply to dry skin covering body from the neck to the toes (including soles of the feet); if patient is bald, apply to forehead, hairline, scalp, and temples. Allow to absorb into skin and dry for 10 minutes prior to getting dressed. Wash hands after application. Do not bathe or shower for at least 6 hours after applying.</p>
<p style="text-indent:-2em;margin-left:4em;">Spinosad should be a portion of a scabies removal regimen that includes washing (hot water) or dry cleaning bedding, clothing, and towels worn or used by the patient during the 3 days before treatment.</p></div>
<div class="block use drugH1Div" id="F11404430"><span class="drugH1">Use: Labeled Indications</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>Head lice:</b> Topical treatment of head lice (<i>Pediculosis capitis</i>) infestation in adults and pediatric patients ≥6 months of age.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Scabies:</b> Topical treatment of scabies infestation in adults and pediatric patients ≥4 years of age.</p></div>
<div class="block cyt drugH1Div" id="F13300078"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">None known.</p></div>
<div class="block dri drugH1Div" id="F11503288"><span class="drugH1">Drug Interactions</span>
<br/><br/><div class="clear"></div><p style="text-indent:0em;display:inline">There are no known significant interactions.</p></div>
<div class="block pri drugH1Div" id="F11502557"><span class="drugH1">Pregnancy Considerations</span>
<p style="text-indent:0em;display:inline">The amount of spinosad absorbed systemically following topical administration is below the limit of quantification (&lt;3 ng/mL). Human studies did not assess the absorption of benzyl alcohol, an ingredient in the product; however, maternal use is not likely to result in fetal exposure.</p></div>
<div class="block brc drugH1Div" id="F11502559"><span class="drugH1">Breastfeeding Considerations</span>
<p style="text-indent:-2em;margin-left:2em;">It is not known if spinosad is present in breast milk following topical application.</p>
<p style="text-indent:-2em;margin-left:2em;">The amount of spinosad absorbed systemically following topical administration is below the limit of quantification (&lt;3 ng/mL). Maternal use is not likely to result in infant exposure to spinosad or benzyl alcohol via breast milk. According to the manufacturer, the decision to breastfeed during therapy should consider the risk of infant exposure, the benefits of breastfeeding to the infant, and the benefits of treatment to the mother. Spinosad should be removed from the breast area with soap and water prior to breastfeeding to avoid direct infant exposure.</p></div>
<div class="block mop drugH1Div" id="F11506587"><span class="drugH1">Monitoring Parameters</span>
<p style="text-indent:0em;display:inline">Monitor scalp for lice</p></div>
<div class="block pha drugH1Div" id="F11503291"><span class="drugH1">Mechanism of Action</span>
<p style="text-indent:0em;display:inline">Insect paralysis and death is caused by central nervous system excitation and involuntary muscle contractions. Spinosad is thought to be both pediculicidal and ovicidal (Stough, 2009).</p></div>
<div class="block phk drugH1Div" id="F11503293"><span class="drugH1">Pharmacokinetics (Adult Data Unless Noted)</span>
<p style="text-indent:0em;display:inline">Absorption: Not absorbed topically (&lt;3 ng/mL in a pediatric patient plasma sampling study); absorption of the benzyl alcohol was not analyzed in this study.</p></div>
<div class="list fbnlist drugH1Div drugBrandNames" id="F58208142"><span class="drugH1">Brand Names: International</span><div class="ibn-search drugBrandNames"></div>
<div class="collapsible-indication brand-names-accordion drugBrandNames"><span class="collapsible-indication-title">International Brand Names by Country</span><div class="collapsible-indication-wrap-frame drugBrandNames"><div class="collapsible-indication-wrap drugBrandNames">For country code abbreviations (<a class="graphic graphic_table" href="/d/html/116421.html" rel="external">show table</a>)<br xmlns=""/><br/><ul>
<li>
<span class="countryCode">(PR)</span> <span class="country">Puerto Rico</span><span class="countrySeparator">: </span><span class="drugName">Natroba</span></li></ul></div>
</div>
</div>
</div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference" id="lexi-content-ref-11487763">
<a name="11487763"></a>Ahlfors CE. Benzyl alcohol, kernicterus, and unbound bilirubin. <i>J Pediatr</i>. 2001;139(2):317-319.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/spinosad-drug-information/abstract-text/11487763/pubmed" id="11487763" target="_blank">11487763</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-6810084">
<a name="6810084"></a>Centers for Disease Control (CDC). Neonatal deaths associated with use of benzyl alcohol—United States. <i>MMWR Morb Mortal Wkly Rep</i>. 1982;31(22):290-291. <a href="https://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm" target="_blank">http://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm</a>
<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/spinosad-drug-information/abstract-text/6810084/pubmed" id="6810084" target="_blank">6810084</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-20660553">
<a name="20660553"></a>Frankowski BL, Bocchini JA Jr; Council on School Health and Committee on Infectious Diseases. Head lice. <i>Pediatrics</i>. 2010;126(2):392-403.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/spinosad-drug-information/abstract-text/20660553/pubmed" id="20660553" target="_blank">20660553</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-9024461">
<a name="9024461"></a>"Inactive" ingredients in pharmaceutical products: update (subject review). American Academy of Pediatrics (AAP) Committee on Drugs. <i>Pediatrics</i>. 1997;99(2):268-278.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/spinosad-drug-information/abstract-text/9024461/pubmed" id="9024461" target="_blank">9024461</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Natroba (spinosad) [prescribing information]. Carmel, IN: ParaPRO; April 2021.</div>
</li>
<li>
<div class="reference">
                  Natroba (spinosad) [prescribing information]. Canton, MS: Allegis Pharmaceuticals; June 2015.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-19188870">
<a name="19188870"></a>Shehab N, Lewis CL, Streetman DD, Donn SM. Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates. <i>Pediatr Crit Care Med</i>. 2009;10(2):256-259.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/spinosad-drug-information/abstract-text/19188870/pubmed" id="19188870" target="_blank">19188870</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-19706558">
<a name="19706558"></a>Stough D, Shellabarger S, Quiring J, Gabrielsen AA Jr. Efficacy and safety of spinosad and permethrin creme rinses for pediculosis capitis (head lice). <i>Pediatrics</i>. 2009;124(3):e389-395.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/spinosad-drug-information/abstract-text/19706558/pubmed" id="19706558" target="_blank">19706558</a>]</span>
</div>
</li></ol></div><div id="topicVersionRevision">Topic 16101 Version 109.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
